Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Acta Oncologica (Stockholm, Sweden)|June 25, 2014
Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapiesAida Kiviniemi, Maria Gardberg, Anu Autio, et al.Molecular Imaging and Biology|July 1, 2015
Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic PlaquesPetteri Rinne, Sanna Hellberg, Max Kiugel, et al.Journal of Neuroinflammation|January 21, 2021
Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosisPetri Elo, Xiang-Guo Li, Heidi Liljenbäck, et al.Frontiers in Immunology|June 5, 2023
High folate receptor expression in gliomas can be detected Maxwell W G Miner, Heidi Liljenbäck, Jenni Virta, et al.Nature Medicine|April 29, 2025
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosisLuisa Klotz, Joost Smolders, Jussi Lehto, et al.Neurobiology of Aging|November 14, 2016
SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish populationPetra Pasanen, Eino Palin, Risto Pohjolan-Pirhonen, et al.Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.Pageof 5